Foundation / Corporation
Alex's Lemonade Stand Foundation (ALSF)
04/08/19 11:59 PM ET
Grants to USA and Canada academic faculty for new, creative approaches to pediatric oncology research. An LOI is required prior to submitting a full application. Funding is intended for research projects that represent a change in direction or an idea that marks a new direction for an investigator.
Alex’s Lemonade Stand Foundation (ALSF) is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. Innovation Grants are designed as seed funding for researchers with a novel approach to pediatric oncology scientific investigation. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research but for which a strong case is made for the potential impact on childhood cancers.
Innovation Grants will support research proposals to be carried out by investigators who are already established, have a recent track record of peer-reviewed publications and evidence of successfully competing for extramural funding. The grant is for two years up to $125,000 per year for direct costs only. A no-cost extension is permitted if progress is demonstrated and budget properly justified.
- Proposal must be hypothesis driven and mechanistic.
- Innovation must be clearly presented.
- Potential for major scientific impact in pediatric oncology is critical.
- While preliminary data are not required, the applicant must demonstrate feasibility of the research plan.
- New: Resource sharing is an expected outcome of a completed project. The review will consider how outputs are shared as a component of impact.
- Grants must be focused on pediatric translational oncology, from understanding basic biologic underpinnings to new therapies.
GrantWatch ID#: 184362
The Innovation Grant is $250,000 over two years.
The grant is for two years. A no-cost extension is permitted if progress is demonstrated and budget properly justified.
- Applicants must have a faculty appointment at an academic institution.
- Applicant may be M.D., D.O., Ph.D, or M.D./Ph.D.
- Track record of publication and funding productivity in the last 5 years must demonstrate that the project can be accomplished by the investigator(s)
- ALSF will only consider letters of intent from U.S. or Canadian institutions. However, the PI need not be a U.S. citizen.
- Institutions must have non-profit tax status
- ALSF does not accept proposals for research utilizing human embryonic stem cells or non-human primates. (Research with human induced pluripotent stem cells is permissible.)
- LOI Due Date: November 1, 2018 (11:59 pm Eastern Time)
- Invitation to Submit Full Application: February 2019
- Full Application Due Date: April 8, 2019 (11:59 pm Eastern Time)
- Award Notification: July 2019
- Project Start Date: October 1, 2019
- Project End Date: September 30, 2021
- Progress Report: September 14, 2020 (with financials ending 8/31/2020)
- Final Report: November 1, 2021 (with financials ending 9/30/2021)
While an Investigator may submit more than one LOI, and in the event that more than one LOI were approved, only one full application per Investigator may be submitted.
One resubmission of a previously ALSF reviewed application is permitted.
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon